Diane Sullivan

Diane Sullivan is a seasoned healthcare executive and board director with extensive experience across life sciences, consumer health, and technology. Currently, they serve as a member of the Board of Directors for both Amarin Corporation and Lexicon Pharmaceuticals, while also operating as a strategic consultant through Diane E Sullivan LLC. Diane has held key leadership positions at notable companies, including Chief Commercial Officer at The Medicines Company, where they played a pivotal role in its acquisition by Novartis. Their educational background includes a Bachelor of Arts in French from Dickinson College and participation in advanced programs at prestigious institutions such as Harvard Business School.